{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:17:24Z","timestamp":1789903044430,"version":"4.0.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.autrev.2017.05.009","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T07:15:26Z","timestamp":1493968526000},"page":"735-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema"],"prefix":"10.1016","volume":"16","author":[{"given":"Yu-ping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-fang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-rui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.05.009_bb0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","article-title":"Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden","volume":"164","author":"Gronhagen","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamadermatol.2013.9026","article-title":"Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus","volume":"150","author":"Wieczorek","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0015","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1610-0387.2007.06554.x","article-title":"Clinical manifestations of cutaneous lupus erythematosus","volume":"5","author":"Kuhn","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.autrev.2017.05.009_bb0020","first-page":"200","article-title":"Cutaneous lupus: insights into pathogenesis and disease classification","volume":"65","author":"Werth","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.autrev.2017.05.009_bb0025","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/08916930600886851","article-title":"Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies","volume":"39","author":"Lee","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2017.05.009_bb0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaut.2014.01.021","article-title":"The classification and diagnosis of cutaneous lupus erythematosus","volume":"48-49","author":"Kuhn","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.05.009_bb0035","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/0961203315610645","article-title":"Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: results from a prospective cohort study","volume":"25","author":"Drucker","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0040","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaad.2014.12.028","article-title":"The natural history of pediatric-onset discoid lupus erythematosus","volume":"72","author":"Arkin","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaad.2013.02.010","article-title":"Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus","volume":"69","author":"Merola","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0050","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archdermatol.2011.3249","article-title":"Autoantibody and clinical profiles in patients with discoid lupus and borderline systemic lupus","volume":"148","author":"Vasquez","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0055","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1038\/jid.2012.207","article-title":"IgG and IgM autoantibody differences in discoid and systemic lupus patients","volume":"132","author":"Chong","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0060","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/acr.21581","article-title":"Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort","volume":"64","author":"Santiago-Casas","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2017.05.009_bb0065","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4103\/0019-5154.87150","article-title":"Skin lesions in lupus erythematosus: a marker of systemic involvement","volume":"56","author":"Das","year":"2011","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0070","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1590\/abd1806-4841.20132042","article-title":"Prognosis of patients with systemic lupus erythematosus and discoid lesions","volume":"88","author":"Skare","year":"2013","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40257-016-0173-9","article-title":"Cutaneous lupus erythematosus: an update on pathogenesis, diagnosis and treatment","volume":"17","author":"Hejazi","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0080","doi-asserted-by":"crossref","first-page":"C162","DOI":"10.12968\/hmed.2015.76.11.C162","article-title":"Cutaneous lupus erythematosus","volume":"76","author":"Tull","year":"2015","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1016\/j.autrev.2017.05.009_bb0085","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13075-015-0706-2","article-title":"Pathophysiology of cutaneous lupus erythematosus","volume":"17","author":"Achtman","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.009_bb0090","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.cyto.2015.01.031","article-title":"The role of cytokines in the pathogenesis of cutaneous lupus erythematosus","volume":"73","author":"Robinson","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2017.05.009_bb0095","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.rdc.2014.04.006","article-title":"The immunopathology of cutaneous lupus erythematosus","volume":"40","author":"Kirchhof","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2017.05.009_bb0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2013.01.007","article-title":"Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review","volume":"41","author":"Yu","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.05.009_bb0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/joim.12057","article-title":"Cutaneous lupus erythematosus: clinical aspects and molecular pathogenesis","volume":"273","author":"Oke","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2017.05.009_bb0110","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/0961203310370344","article-title":"Photosensitivity, phototesting, and photoprotection in cutaneous lupus erythematosus","volume":"19","author":"Kuhn","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0115","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1177\/0961203310370045","article-title":"Cutaneous lupus erythematosus: recent lessons from animal models","volume":"19","author":"Ghoreishi","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0120","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1177\/0961203310370046","article-title":"Pathogenesis of cutaneous lupus erythematosus: common and different features in distinct subsets","volume":"19","author":"Wenzel","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0125","doi-asserted-by":"crossref","first-page":"7074829","DOI":"10.1155\/2016\/7074829","article-title":"Cytokines and effector\/regulatory cells characterization in the physiopathology of cutaneous lupus erythematous: a cross-sectional study","volume":"2016","author":"Mendez-Flores","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2017.05.009_bb0130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejim.2010.03.004","article-title":"IL-17 in cutaneous lupus erythematosus","volume":"21","author":"Tanasescu","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2017.05.009_bb0135","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1177\/0961203312451200","article-title":"Gene expression of cytokines (TNF-alpha, IFN-gamma), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus","volume":"21","author":"Rana","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00296-013-2855-4","article-title":"A meta-analysis of the association of IL-6-174 G\/C and \u2212572 G\/C polymorphisms with systemic lupus erythematosus risk","volume":"34","author":"Yang","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2017.05.009_bb0145","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1177\/0961203315588971","article-title":"Association of the interleukin-6 polymorphisms with systemic lupus erythematosus: a meta-analysis","volume":"24","author":"Cui","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0150","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s10067-014-2741-9","article-title":"Elevated levels of serum sCXCL16 in systemic lupus erythematosus; potential involvement in cutaneous and renal manifestations","volume":"33","author":"Qin","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0155","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/0961203310392424","article-title":"Serum levels of the regulatory cytokines transforming growth factor-beta and interleukin-10 are reduced in patients with discoid lupus erythematosus","volume":"20","author":"Antiga","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0160","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jdermsci.2013.11.007","article-title":"Differential expression of BAFF and its receptors in discoid lupus erythematosus patients","volume":"73","author":"Chong","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2017.05.009_bb0165","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0961203313483377","article-title":"High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE)","volume":"22","author":"Abdulahad","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0170","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ygeno.2014.06.003","article-title":"Differential gene expression analysis in CCLE lesions provides new insights regarding the genetics basis of skin vs. systemic disease","volume":"104","author":"Dey-Rao","year":"2014","journal-title":"Genomics"},{"key":"10.1016\/j.autrev.2017.05.009_bb0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)61689-6","article-title":"Plasmacytoid dendritic cells (natural interferon- alpha\/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions","volume":"159","author":"Farkas","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0180","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0961203311398515","article-title":"LL-37 expression in the skin in systemic lupus erythematosus","volume":"20","author":"Sun","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0961203306075384","article-title":"Chloroquine treatment reduces the number of cutaneous HLA-DR+ and CD1a+ cells in patients with systemic lupus erythematosus","volume":"16","author":"Wozniacka","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0190","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/03009742.2010.528020","article-title":"Ultraviolet radiation-induced cytokines promote mast cell accumulation and matrix metalloproteinase production: potential role in cutaneous lupus erythematosus","volume":"40","author":"Van Nguyen","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0195","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5114\/pjp.2015.57253","article-title":"Mast cells in systemic and cutaneous lupus erythematosus","volume":"66","author":"Kaczmarczyk-Sekula","year":"2015","journal-title":"Pol J Pathol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0200","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2230.2010.03996.x","article-title":"Expression of interleukin-17 is correlated with interferon-alpha expression in cutaneous lesions of lupus erythematosus","volume":"36","author":"Oh","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2133.2011.10610.x","article-title":"Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus","volume":"166","author":"Chong","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.semarthrit.2004.07.002","article-title":"Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients","volume":"34","author":"Sherer","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.009_bb0215","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.009_bb0220","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.05.009_bb0225","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.4049\/jimmunol.0902514","article-title":"Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway","volume":"184","author":"Deng","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2016.02.007","article-title":"The features of skin inflammation induced by lupus serum","volume":"165","author":"Liu","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0235","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.05.009_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/809389","article-title":"Chinese SLE treatment and research group registry: III. Association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus","volume":"2014","author":"Li","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2017.05.009_bb0245","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s10067-015-2941-y","article-title":"Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort","volume":"34","author":"Arroyo-Avila","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0250","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1073\/pnas.0832411100","article-title":"A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen","volume":"100","author":"Xue","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.05.009_bb0255","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.20090585","article-title":"Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway","volume":"206","author":"Espinosa","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.05.009_bb0260","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1073\/pnas.0800159105","article-title":"TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved","volume":"105","author":"Keeble","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.05.009_bb0265","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.reuma.2014.03.007","article-title":"Multicentric prevalence study of anti P ribosomal autoantibodies in juvenile onset systemic lupus erythematosus compared with adult onset systemic lupus erythematosus","volume":"11","author":"Pisoni","year":"2015","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.autrev.2017.05.009_bb0270","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1128\/CVI.13.1.77-83.2006","article-title":"International multicenter evaluation of autoantibodies to ribosomal P proteins","volume":"13","author":"Mahler","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0275","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/ar3244","article-title":"Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus","volume":"13","author":"Barkhudarova","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.009_bb0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jcla.21543","article-title":"Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus","volume":"27","author":"Li","year":"2013","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.autrev.2017.05.009_bb0285","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/rheumatology\/kep142","article-title":"Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus","volume":"48","author":"Haddouk","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.05.009_bb0290","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/rheumatology\/41.12.1357","article-title":"Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients","volume":"41","author":"Gerli","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.05.009_bb0295","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1191\/0961203302lu209oa","article-title":"Antiribosomal P protein antibodies in Chilean SLE patients: no association with renal disease","volume":"11","author":"Massardo","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0300","first-page":"860","article-title":"Anti-ribosomal P antibodies related to depression in early clinical course of systemic lupus erythematosus","volume":"18","author":"Karimifar","year":"2013","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.autrev.2017.05.009_bb0305","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0961203314560003","article-title":"The association of serum anti-ribosomal P antibody with clinical and serological disorders in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"24","author":"Shi","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/art.38891","article-title":"Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus","volume":"67","author":"Shi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0315","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/0961203313513820","article-title":"The association of anti-annexin1 antibodies with the occurrence of skin lesions in systemic lupus erythematosus","volume":"23","author":"Meng","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0320","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/03009742.2014.928946","article-title":"Anti-high mobility group box 1 (anti-HMGB1) antibodies are not related to the occurrence of cutaneous lesions in systemic lupus erythematosus","volume":"44","author":"Tan","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0325","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1365-2133.2011.10244.x","article-title":"T cell-specific overexpression of interleukin-27 receptor alpha subunit (WSX-1) prevents spontaneous skin inflammation in MRL\/lpr mice","volume":"164","author":"Kido","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0330","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1365-2133.2007.08166.x","article-title":"Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus","volume":"157","author":"Jarvinen","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0335","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/ard.2007.070359","article-title":"Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients","volume":"67","author":"Reefman","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.009_bb0340","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1073\/pnas.0910371106","article-title":"Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling","volume":"106","author":"Pflegerl","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.05.009_bb0345","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/exd.12934","article-title":"Interleukin-6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus","volume":"25","author":"Birner","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0350","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/S1807-59322011000100014","article-title":"IL-2, IL-5, TNF-alpha and IFN-gamma mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions","volume":"66","author":"Carneiro","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.autrev.2017.05.009_bb0355","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/art.20851","article-title":"The intracellular 52-kd Ro\/SSA autoantigen in keratinocytes is up-regulated by tumor necrosis factor alpha via tumor necrosis factor receptor I","volume":"52","author":"Gerl","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.009_bb0360","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/jid.2008.332","article-title":"UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription","volume":"129","author":"Bashir","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0365","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2249.2006.03251.x","article-title":"Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes","volume":"147","author":"Li","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0370","first-page":"159","article-title":"Anti C1q antibodies in cutaneous lupus erythematosus","volume":"48","author":"Balanescu","year":"2010","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.autrev.2017.05.009_bb0375","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygeno.2014.11.004","article-title":"Genome-wide transcriptional profiling of chronic cutaneous lupus erythematosus (CCLE) peripheral blood identifies systemic alterations relevant to the skin manifestation","volume":"105","author":"Dey-Rao","year":"2015","journal-title":"Genomics"},{"key":"10.1016\/j.autrev.2017.05.009_bb0380","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/jid.2010.244","article-title":"Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNlambda) in cutaneous lupus erythematosus","volume":"131","author":"Zahn","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0385","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1365-2133.2011.10479.x","article-title":"Interferon-alpha stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus","volume":"165","author":"Zahn","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0390","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00281-015-0550-0","article-title":"Lupus erythematosus revisited","volume":"38","author":"Kuhn","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0395","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/jid.2013.269","article-title":"Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis","volume":"134","author":"Jabbari","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0400","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13075-015-0839-3","article-title":"A subset of CD163+ macrophages displays mixed polarizations in discoid lupus skin","volume":"17","author":"Chong","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.009_bb0405","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4103\/0377-4929.168850","article-title":"Immunofluorescence profile of discoid lupus erythematosus","volume":"58","author":"Bharti","year":"2015","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0410","first-page":"103","article-title":"The gender disparity of immunoreactants in lesional skin of lupus erythematosus patients","volume":"30","author":"Yu","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0415","article-title":"Correlation of cutaneous immunoreactants in lesional skin with the serological disorders and disease activity of systemic lupus erythematosus","volume":"8","author":"Luo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.009_bb0420","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2133.2003.05738.x","article-title":"The lupus band: do the autoantibodies target collagen VII?","volume":"150","author":"Alahlafi","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0425","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1191\/0961203303lu1074oa","article-title":"The basement membrane zone in patients with systemic lupus erythematosus: immunofluorescence studies in the skin, kidney and amniochorion","volume":"13","author":"Alahlafi","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0430","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.0303-6987.2005.00373.x","article-title":"Activation\/inactivation of the classical pathway of complement in non-lesional skin of patients with systemic lupus erythematosus","volume":"32","author":"Alahlafi","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0435","first-page":"1124","article-title":"The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus","volume":"159","author":"Wozniacka","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0440","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2230.2009.03297.x","article-title":"Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis","volume":"34","author":"Grassi","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0445","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3109\/01913123.2013.816400","article-title":"Immunohistochemical expression of granzyme B and perforin in discoid lupus erythematosus","volume":"37","author":"Abdou","year":"2013","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.autrev.2017.05.009_bb0450","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/ard.2009.120543","article-title":"ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry","volume":"69","author":"Kim-Howard","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.009_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014212","article-title":"Polymorphisms of the ITGAM gene confer higher risk of discoid cutaneous than of systemic lupus erythematosus","volume":"5","author":"Jarvinen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.009_bb0460","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0961203311435266","article-title":"Association of chemokine CXCL12-3'G801A polymorphism with systemic lupus erythematosus in a Han Chinese population","volume":"21","author":"Wu","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.009_bb0465","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/sj.gene.6364387","article-title":"Disease association of the interleukin-18 promoter polymorphisms in Taiwan Chinese systemic lupus erythematosus patients","volume":"8","author":"Lin","year":"2007","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2017.05.009_bb0470","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000101","article-title":"DNA methylation patterns in naive CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus","volume":"2","author":"Renauer","year":"2015","journal-title":"Lupus Sci Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T07:20:33Z","timestamp":1658992833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":94,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1568997217301295"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.009","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}